Institution statistics

ACIES SAS - France 

Ranking results:

Past rankings:
2009
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:600-700
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:800-900
Total Project Funding:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:600-700
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:800-900
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 23
As coordinator: 0
As participant: 23
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2013 0 16.433.017 314.716 2
2012 0 22.459.233 770.486 4
2011 0 19.805.091 351.774 3
2010 0 11.929.250 0 1
2009 0 11.181.411 385.566 1
2008 0 20.081.796 1.032.886 2
2007 0 14.874.435 864.001 3
2006 0 32.208.760 1.096.725 3
2005 0 11.605.321 985.630 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
NOVAMEN SAS14
UNIVERSITY COLLEGE LONDON8
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE6
UNIVERSITAET ZUERICH6
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
DEUTSCHES KREBSFORSCHUNGSZENTRUM4
GENETHON4
LUNDS UNIVERSITET4
UNIVERSITY OF HELSINKI4
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
KING'S COLLEGE LONDON3
LEIDEN UNIVERSITY MEDICAL CENTER3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
MEDICAL RESEARCH COUNCIL3
PROJETS ET RESEAUX DE RECHERCHE3
UNIVERSITAETSKLINIKUM FREIBURG3
VTT TECHNICAL RESEARCH CENTRE OF FINLAND3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACADEMISCH ZIEKENHUIS GRONINGEN2
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
ALBERT LUDWIGS UNIVERSITAET FREIBURG2
CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
EUROPAEISCHES INSTITUT FUER FORSCHUNG UND ENTWICKLUNG VON TRANSPLANTATIONSSTRATEGIEN2
EXBIO PRAHA AS2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
FONDAZIONE HUMANITAS PER LA RICERCA2
FONDAZIONE TELETHON2
GATC BIOTECH2
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT2
IMMUNE DISEASE INSTITUTE2
INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY2
JOSLIN DIABETES CENTER2
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN2
MEDICEL OY2
MEDIZINISCHE HOCHSCHULE HANNOVER2
MEDIZINISCHE UNIVERSITAET INNSBRUCK2
MOLECULAR MEDICINE2
OTTO VON GUERICKE UNIVERSITAET MAGDEBURG2
PAUL EHRLICH INSTITUT2
PROJETS ET RESEAUX DE RECHERCHE SAS2
ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
TTYSAATIO2
UNIVERSITA DEGLI STUDI DI FIRENZE2
UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA2
UNIVERSITA VITA SALUTE SAN RAFFAELE2
UNIVERSITAETSSPITAL BASEL2
UNIVERSITE CATHOLIQUE DE LOUVAIN2
UNIVERSITE PAUL SABATIER TOULOUSE III2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERSITY OF TURKU2
VIB2
VRIJE UNIVERSITEIT BRUSSEL2
WARTSILA FINLAND OY2
"RITA LEVIMONTALCINI" EUROPEAN BRAIN RESEARCH INSTITUTE FOUNDATION1
ALTONABIOTEC1
ARK THERAPEUTICS LIMITED1
AROS APPLIED BIOTECHNOLOGY AS1
ASOCIACION CIVIL IMPACTA SALUD Y EDUCACION1
ASSOCIATION FRANCAISE CONTRE LES MYOPATHIES1
ATMEL HELLAS MULTIMEDIA & COMMUNICATION GROUP1
AVIO S P A1
AXXAM1
BIOBYTE SOLUTIONS1
BIOTECHNOLOGICKY USTAV AV CR VVI1
CAMECA SAS1
CENTRE D'ELABORATION DES MATERIAUX ET D'ETUDES STRUCTURALES1
CENTRE EUROPEEN DE RECHERCHE ET DE FORMATION AVANCEE EN CALCUL SCIENTIFIQUE1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CENTRE LEON BERARD1
CENTRUM FUR ANGEWANDTE NANOTECHNOLOGIE1
CHALMERS TEKNISKA HOEGSKOLA AKTIEBOLAG1
COMITE EUROPEEN DE NORMALISATION1
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLOPROTEINE PARAMAGNETICHE1
CONSORZIO NAZIONALE INTERUNIVERSITARIO PER LA NANOELETTRONICA1
CONVERTEAM TECHNOLOGY1
CYPROTEX DISCOVERY LIMITED1
DAKO DENMARK1
DELSITECH1
DEUTSCHES ZENTRUM FUER LUFT UND RAUMFAHRT EV1
DIAGENIC ASA1
DIPARTIMENTO DI GENETICA BIOLOGIA E BIOCHIMICA UNIVERSITA DI TORINO1
DNV GL SE1
DSM RESINS BV1
ECOLE CENTRALE DE LYON1
ECOLE CENTRALE DE NANTES1
ENTELECHON1
ETABLISSEMENT FRANCAIS DU SANG RHONEALPES1
EUROPEAN FEDERATION FOR PHARMACEUTICAL SCIENCES1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN NEUROMUSCULAR CENTRE1
EUROPEAN ORGANISATION FOR RARE DISEASES1
EUROPEAN SYNCHROTRON RADIATION FACILITY1
Constancy:

Total number of partners:404

Partner loyalty:
Frequent Partner: (> 2 projects): 98
Rare Partner: 306

Frequent / Rare Partner Ratio: 0.32

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES16
RTD HORIZONTAL TOPICS6
INDUSTRY AND TECHNOLOGY4
SOCIAL AND ECONOMIC CONCERNS2
MEASUREMENTS AND STANDARDS1
PROTECTING MAN AND HIS ENVIRON1
ENERGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2013-09-01Translating disease to cardiovascular health TRANSCARDparticipant5.884.6438
2013-01-01A systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol RESOLVEparticipant10.548.37414
2012-12-01To decipher the optimal management of systemic sclerosis DESSCIPHERparticipant2.999.83515
2012-08-01From sea-bed to test-bed: harvesting the potential of marine microbes for industrial biotechnology SeaBioTechparticipant7.461.71616
2012-03-01DARPin Targeted Magnetic Hyperthermic Therapy for Glioblastoma DARTRIXparticipant5.998.1348
2012-01-01VitaminD3-Omega3-Home Exercise- HeALTHy Ageing and Longevity Trial DO-HEALTHparticipant5.999.54824
2011-05-01INOvative Energy MANagement System for Cargo SHIP INOMANSĀ²HIPparticipant2.184.60212
2011-05-01HER Imaging and Molecular Interaction Mapping in Breast Cancer IMAGINTparticipant5.683.59011
2011-01-01Systems biology of liver cancer: an integrative genomic-epigenomic approach MODHEPparticipant11.936.89918
2010-01-01Cutaneous and Mucosal HIV Vaccination CUT'HIVACparticipant11.929.25018
2009-01-01Persisting Transgenesis PERSISTparticipant11.181.41129
2008-10-01Standardisation and improvement of generic pre-analytical tools and procedures for in vitro diagnostics SPIDIAparticipant8.981.79617
2008-04-01Systems biology of T-cell activation in health and disease SYBILLAparticipant11.100.00022
2007-01-01Development, characterisation and validation of new and original models for Alzheimer's Disease' MEMORIESparticipant2.374.68911
2007-01-01Baculovirus vectors for gene therapy BACULOGENESparticipant2.499.7469
2007-01-01Translational research in Europe - Assessment and treatment of neuromuscular diseases TREAT-NMDparticipant10.000.00027
2006-11-01Chimaeric T-cells for the treatment of paediatric cancers CHILDHOPEparticipant3.208.7609
2006-06-01PULLing the limits of NANOCmos electronics PULLNANOparticipant25.000.00051
2006-01-01Self-adaptive embedded technologies for pervasive computing architectures AETHERparticipant4.000.00016
2005-12-15European Union Microdose AMS Partnership Programme EUMAPPparticipant2.094.37011
2005-12-01REdox Antimalarial Drug discovery READ-UPparticipant2.000.0007
2005-12-01Optimised and novel oncolytic adenoviruses and pox viruses in the treatment of cancer: Virotherapy combined with molecular chemotherapy THERADPOXparticipant2.411.00610
2005-03-01Towards Lean Combustion TLCparticipant5.099.94519

Alias institution names:
  • ACIES SAS

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum